跳至主要内容
临床试验/NCT07013409
NCT07013409已完成不适用

Safety and Efficacy of Lacticaseibacillus Rhamnosus LRa05, Lactobacillus Crispatus LCr86 and Limosilactobacillus Reuteri LR08 on Hormone Metabolism, Body Composition, and Emotional Regulation in Overweight Women

Wecare Probiotics Co., Ltd.2 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2025年7月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
102
试验地点
2
主要终点
The changes of estradiol before and after the intervention

研究概览

简要总结

To evaluate the regulatory effect of probiotics formula on visceral fat metabolism and sex hormone balance in obese women.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •Age: 18 to 40 years old, female, BMI ≥ 25 kg/m
  • •Be willing to receive follow-up during the intervention period.
  • •Be willing to provide two blood, urine and fecal samples during the intervention period.
  • •Be willing to take the compound probiotics by oneself every day during the intervention period.
  • •Have good hearing and be able to hear and understand all instructions during the intervention period.

排除标准

  • •Suffering from digestive system diseases, mainly gastrointestinal diseases (celiac disease, ulcerative colitis, Crohn's disease).
  • •Suffering from severe neurological disorders (epilepsy, stroke, severe head trauma, meningitis within the past 10 years, brain surgery, brain tumor, long-term coma - excluding general anesthesia).
  • •Have received/are currently receiving treatment for the following mental illnesses: alcohol/drug/substance abuse dependence, schizophrenia, psychosis, bipolar disorder.
  • •Take medication for depression or low mood.
  • •Suffering from internal organ failure (such as heart, liver or kidney failure, etc.).
  • •Have received radiotherapy or chemotherapy in the past.
  • •Have received general anesthesia surgery/procedures within the past three years, or plan to receive general anesthesia procedures/surgeries within the next three months during this trial.
  • •Have suffered from hepatitis (hepatitis B, hepatitis C), HIV or syphilis in the past.

研究组 & 干预措施

Probiotic Group

Experimental

Take 30 billion CFU of complex probiotics every day

干预措施: Probiotic (Dietary Supplement)

Placebo Group

Placebo Comparator

Taking maltodextrin 3 g/day.

干预措施: Maltodextrin (Dietary Supplement)

结局指标

主要结局

The changes of estradiol before and after the intervention

时间窗: 0, 1, 2, 3 months

The serum estrogen content of the subjects before and after the intervention was detected by enzyme-linked immunosorbent assay.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验